List view / Grid view

Dr Ana Pereira Ribeiro (Immunocore)

 

article

A T cell receptor immunotherapy against a novel target

In this Q&A, Associate Director, Research at Immunocore, Dr Ana…

7 June 2024 | By

In this Q&A, Associate Director, Research at Immunocore, Dr Ana Pereira Ribeiro, talks about IMC-R117C, a T cell receptor bispecific immunotherapy directed towards a novel target, PIWIL1, and about to enter Phase I testing in colorectal and gastrointestinal cancers.